Original Article
Does the Use of a Handheld Fan Improve Chronic Dyspnea? A Randomized, Controlled, Crossover Trial

https://doi.org/10.1016/j.jpainsymman.2009.09.024Get rights and content
Under an Elsevier user license
open archive

Abstract

Context

Dyspnea is a disabling distressing symptom that is common in advanced disease affecting millions of people worldwide. Current palliative strategies are partially effective in managing this symptom; facial cooling has been shown to reduce the sensation of breathlessness when induced in volunteers but has not been formally investigated in dyspnea associated with disease.

Objective

The objective of this study was to investigate whether a handheld fan reduces the sensation of breathlessness in such patients, enhancing palliative approaches.

Methods

The effectiveness of a handheld fan (blowing air across the nose and mouth) in reducing the sensation of breathlessness was assessed in patients with advanced disease. Fifty participants were randomized to use a handheld fan for five minutes directed to their face or leg first and then crossed over to the other treatment. The primary outcome measure was a decrease of greater than 1 cm in breathlessness recorded on a 10 cm visual analog scale (VAS).

Results

There was a significant difference in the VAS scores between the two treatments, with a reduction in breathlessness when the fan was directed to the face (P = 0.003).

Conclusion

This study supports the hypothesis that a handheld fan directed to the face reduces the sensation of breathlessness. The fan was acceptable to participants: it is inexpensive, portable, enhances self-efficacy, and available internationally. It should be recommended as part of a palliative management strategy for reducing breathlessness associated with advanced disease.

Key Words

Dyspnea
handheld fan
palliation

Cited by (0)

Dr. Lynch was supported by Cancer Research UK (CUK) grant number C14303/A8646. Dr. Booth was partially supported by a SuPAC personal award and Cicely Saunders International during the period of the study. There were no conflicts of interest.

Clinical Trials Registration: ISRCTN44193804.